Efficacy of hematopoietic stem cell transplantation treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta‐analysis

Citations Over TimeTop 11% of 2023 papers

Abstract

This meta-analysis and systematic review suggested that HSCT can be effective in the treatment of refractory CIDP. Whilst there are risks involved, HSCT may be a beneficial and viable therapy for refractory CIDP when carefully evaluated.

Related Papers

• → Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.(1990)78 cited
• → Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases(2019)14 cited
• → Treatment of plasmapheresis refractory thrombotic thrombocytopenic purpura with double-filtration membrane plasmapheresis(2013)3 cited
• [Plasmapheresis in neuromuscular diseases. Personal cases].(1989)
• → Effects of plasmapheresis on refractory cholestatic pruritus in patients with PBC: prospective analysis of 129 procedures(2016)